You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The funding will support the firm's international market expansion on the heels of the release of Lifebit CloudOS version 2.0 this week.
The French bioinformatics and genomic services company will help Dana-Farber manage clinical research data for the cancer center's new interpretive genomics program.
Researchers at Mount Sinai, NYU School of Medicine, and Weill Cornell Medicine sequenced hundreds of SARS-CoV-2 genomes from NYC patients for phylogenetic analyses.
The genome mapping firm had fallen out of compliance with respect to its loan agreement with Innovatus and will prepay $5 million toward the loan principal.
The deal will allow users of MGI's DNBSEQ sequencers to convert previously validated assays to the platform and access Sophia's analytics technology.
With the partnership, the companies aim to help researchers streamline their workflows from sample collection to enrichment to interpretation.
Unlike the Hi-C chromosome conformation assay, the Pore-C technique reveals information that's lost with short-read sequencing.
The two companies had worked closely together since Parabricks spun out of the University of Michigan in 2015 and entered the Nvidia accelerator program.
Computational hardware maker Nvidia has purchased Parabricks, which has applied GPU technology to bring whole-genome sequencing processing time under an hour.
IQvia, the lead investor in this round, will work with BC Platforms to integrate genomic and clinical data in a secure environment to support biomedical research.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.